共 127 条
[1]
Best WR(1976)Development of a Crohn’s disease activity index: national cooperative Crohn’s disease study Gastroenterology 70 439-444
[2]
Becktel JM(2010)Infliximab, azathioprine, or combination therapy for Crohn’s disease N Engl J Med 362 1383-1395
[3]
Singleton JW(2002)Maintenance infliximab for Crohn’s disease: the ACCENT I randomised trial Lancet 359 1541-1549
[4]
Kern F(2005)A randomized, double-blind, controlled withdrawal trial in Crohn’s disease patients in long-term remission on azathioprine Gastroenterology 128 1812-1818
[5]
Colombel JF(2002)Long term outcome of patients with active Crohn’s disease exhibiting extensive and deep ulcerations at colonoscopy Am J Gastroenterol 97 947-953
[6]
Sandborn WJ(2007)Clinical course in Crohn’s disease: results of a Norwegian population-based ten-year follow-up study Clin Gastroenterol Hepatol 5 1430-1438
[7]
Reinisch W(1992)Endoscopic monitoring of Crohn’s disease treatment: a prospective, randomized clinical trial. The Groupe d’Etudes Therapeutiques des Affections Inflammatoires Digestives Gastroenterology 102 1647-1653
[8]
Hanauer SB(2011)Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn’s disease Aliment Pharmacol Ther 34 125-145
[9]
Feagan BG(2009)Magnetic resonance for assessment of disease activity and severity in Crohn disease Gut 58 1113-1120
[10]
Lichtenstein GR(2005)Magnetic resonance imaging compared with ileocolonoscopy in evaluating disease severity in Crohn’s disease Clin Gastroenterol Hepatol 3 1221-1228